Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Barros, Mário H M ^a   Segges, Priscilla ^a,b   Vera Lozada, Gabriela ^b   Hassan, Rocio ^b   Niedobitek, Gerald ^a,c  

^a Institute for Pathology   (Germany)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c SANA KLINIKUM OFFENBACH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; LYSOZYME; STAT1 PROTEIN; TRANSCRIPTION FACTOR FOXP3; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; CELL COMPOSITION; CELL COUNT; CELL POPULATION; CLASSICAL HODGKIN LYMPHOMA; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; LYZ GENE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLARIZATION; PROGRESSION FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAT1 GENE; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TUMOR MICROENVIRONMENT; DISEASE FREE SURVIVAL; HODGKIN DISEASE; IMMUNOLOGY; METABOLISM; MORTALITY;

HUMAN HERPESVIRUS 4;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DISEASE-FREE SURVIVAL; FEMALE; HODGKIN DISEASE; HUMANS; MACROPHAGES; MALE; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES; TUMOR MICROENVIRONMENT;

EID: 84929352980     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124531     Document Type: Article

References (77)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2008. doi: 10.1016/j.anndiagpath.2012.05.004 PMID: 22683202
2. Barros MHM, Hassan R, Niedobitek G. Disease patterns in pediatric classical Hodgkin lymphoma: a report from a developing area in Brazil. Hematol Oncol. 2011;29:190-5. doi: 10.1002/hon. 984 PMID: 21374695
3. Barros MHM, Vera-Lozada G, Soares F a, Niedobitek G, Hassan R. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection. Int J Cancer. 2012;131:1142-52. doi: 10.1002/ijc.27314 PMID: 22025264
4. Barros MHM, Hassan R, Niedobitek G. Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact. Clin Cancer Res. 2012;18:3762-71. doi: 10.1158/1078-0432. CCR-12-0129 PMID: 22645050
5. Jarrett RF, Stark GL, White J, Angus B, Alexander FE, Krajewski AS, et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood. 2005;106:2444-51. doi: 10.1182/blood-2004-09-3759 PMID: 15941916
6. Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med. 2010;362:875-85. doi: 10.1056/NEJMoa0905680 PMID: 20220182
7. Tzankov A, Matter MS, Dirnhofer S. Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma. Pathobiology. 2010;77:301-8. doi: 10.1159/000321567 PMID: 21266828
8. Kamper P, Bendix K, Hamilton-Dutoit S, Honoré B, Nyengaard JR, D'Amore F. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma. Haematologica. 2011;96:269-76. doi: 10.3324/haematol.2010.031542 PMID: 21071500
9. Yoon DH, Koh YW, Kang HJ, Kim S, Park C-S, Lee S-W, et al. CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma. Eur J Haematol. 2012;88:292-305. doi: 10.1111/j.1600-0609.2011.01731.x PMID: 22044760
10. Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010;22:231-7. doi: 10.1016/j.coi.2010.01.009 PMID: 20144856
11. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32:593-604. doi: 10.1016/j.immuni.2010.05.007 PMID: 20510870
12. Katze MG, He Y, Gale M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002;2:675-87. doi: 10.1038/nri888 PMID: 12209136
13. Fiorcari S, Martinelli S, Bulgarelli J, Audrito V, Zucchini P, Colaci E, et al. Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia. Haematologica. 2015;100:253-62. Available: http://www.haematologica.org/content/early/2014/11/10/haematol.2014. 113217.abstract doi: 10.3324/haematol.2014.113217 PMID: 25398834
14. Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F, et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology. 2014;59:130-142. doi: 10.1002/hep. 26607 PMID: 23832548
15. Waddell A, Ahrens R, Steinbrecher K, Donovan B, Rothenberg ME, Munitz A, et al. Colonic Eosinophilic Inflammation in Experimental Colitis Is Mediated by Ly6Chigh CCR2+ Inflammatory Monocyte/Macrophage-Derived CCL11. J Immunol. 2011;186:5993-6003. doi: 10.4049/jimmunol.1003844 PMID: 21498668
16. Wang Y-C, He F, Feng F, Liu X-W, Dong G-Y, Qin H-Y, et al. Notch Signaling Determines the M1 versus M2 Polarization of Macrophages in Antitumor Immune Responses. Cancer Res. 2010;70:4840-4849. doi: 10.1158/0008-5472. CAN-10-0269 PMID: 20501839
17. Ruffell D, Mourkioti F, Gambardella A, Kirstetter P, Lopez RG, Rosenthal N, et al. A CREB-C/EBPβ cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci. 2009;106:17475-17480. doi: 10.1073/pnas.0908641106 PMID: 19805133
18. Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation). Blood. 2005;107:2112-2122. Available: http://www.bloodjournal.org/content/107/5/2112. abstract PMID: 16269622
19. Leopold Wager CM, Hole CR, Wozniak KL, Olszewski MA, Wormley FL. STAT1 Signaling Is Essential for Protection against Cryptococcus neoformans Infection in Mice. J Immunol. 2014;193:4060-4071. doi: 10.4049/jimmunol.1400318 PMID: 25200956
20. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Perspective Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines. Immunity. 2014;41:14-20. doi: 10.1016/j.immuni.2014.06.008 PMID: 25035950
21. Zhang Y, Wang Y, Lu M, Qiao X, Sun B, Zhang W, et al. Modular Analysis of Bioinformatics Demonstrates a Critical Role for NF-κB in Macrophage Activation. Inflammation. 2014;37:1240-1253. doi: 10. 1007/s10753-014-9851-z PMID: 24577727
22. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010;10:170-181. Available: doi: 10.1038/nri2711 PMID: 20154735
23. Cao S, Liu J, Song L, Ma X. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J Immunol. 2005;174:3484-92. Available: http://www.pubmedcentral. nih.gov/articlerender.fcgi?artid=2955976&tool = pmcentrez&rendertype = abstract PMID: 15749884
24. Van den Bosch MWM, Palsson-Mcdermott E, Johnson DS, O'Neill LAJ. LPS Induces the Degradation of Programmed Cell Death Protein 4 (PDCD4) to Release Twist2, Activating c-Maf Transcription to Promote Interleukin-10 Production. J Biol Chem. 2014;289:22980-22990. doi: 10.1074/jbc. M114.573089 PMID: 24982420
25. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. The American Society for Clinical Investigation; 2012;122:787-795. doi: 10.1172/JCI59643 PMID: 22378047
26. Buechler C, Ritter M, Orsó E, Langmann T, Klucken J, Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol. 2000;67:97-103. Available: http://www.ncbi.nlm.nih.gov/pubmed/10648003 PMID: 10648003
27. Sulahian TH, Högger P, Wahner a E, Wardwell K, Goulding NJ, Sorg C, et al. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine. 2000;12:1312-21. doi: 10.1006/cyto.2000.0720 PMID: 10975989
28. Barros MHM, Hauck F, Dreyer JH, Kempkes B, Niedobitek G. Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages. PLoS One. 2013;8:e80908. doi: 10. 1371/journal.pone.0080908 PMID: 24260507
29. Fuentes-Duculan J, Suarez-Farinas M, Zaba LC, Nograles KE, Pierson KC, Mitsui H, et al. A Subpopulation of CD163-Positive Macrophages Is Classically Activated in Psoriasis. J Invest Dermatol. 2010;130:2412-2422. Available: doi: 10.1038/jid.2010.165 PMID: 20555352
30. Barros MHM, Scheliga A, De Matteo E, Minnicelli C, Soares F a, Zalcberg IR, et al. Cell cycle characteristics and Epstein-Barr virus are differentially associated with aggressive and non-aggressive subsets of Hodgkin lymphoma in pediatric patients. Leuk Lymphoma. 2010;51:1513-22. doi: 10.3109/10428194.2010.489243 PMID: 20687799
31. Bartlett JA, Goldklang AR, Schleifer SJ, Keller SE. Immune function in healthy inner-city children. Clin Diagn Lab Immunol. 2001;8:740-6. doi: 10.1128/CDLI.8.4.740-746.2001 PMID: 11427420
32. Luebke RW, Chen DH, Dietert R, Yang Y, Luster MI. Immune System Maturity and Sensitivity to Chemical Exposure. J Toxicol Environ Health. 2006;69:811-825. doi: 10.1080/15287390600591496
33. Faria AMC, de Moraes SM, de Freitas LHF, Speziali E, Soares TF, Figueiredo-Neves SP, et al. Variation rhythms of lymphocyte subsets during healthy aging. Neuroimmunomodulation. 2008;15:365-79. doi: 10.1159/000156478 PMID: 19047812
34. Erkeller-Yuksel FM, Deneys V, Yuksel B, Hannet I, Hulstaert F, Hamilton C, et al. Age-related changes in human blood lymphocyte subpopulations. J Pediatr. 1992;120:216-22. Available: http://www.ncbi. nlm.nih.gov/pubmed/1735817 PMID: 1735817
35. Heldrup J, Kalm O, Prellner K. Blood T and B lymphocyte subpopulations in healthy infants and children. Acta Paediatr. 1992;81:125-32. Available: http://www.ncbi.nlm.nih.gov/pubmed/1515755 PMID: 1515755
36. Hu X, Ivashkiv LB. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity. 2009;31:539-50. doi: 10.1016/j.immuni.2009. 09.002 PMID: 19833085
37. Verbeke CS, Wenthe U, Bergler WF, Zentgraf H. Characterization of the expanded T cell population in infectious mononucleosis: apoptosis, expression of apoptosis-related genes, and Epstein-Barr virus (EBV) status. Clin Exp Immunol. 2000;120:294-300. doi: 10.1046/j.1365-2249.2000.01181.x PMID: 10792379
38. Noël W, Raes G, Hassanzadeh Ghassabeh G, De Baetselier P, Beschin A. Alternatively activated macrophages during parasite infections. Trends Parasitol. 2014;20:126-133. doi: 10.1016/j.pt.2004.01. 004
39. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2013;229:176-185. doi: 10.1002/path.4133 PMID: 23096265
40. Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Müller W, et al. Differential Roles of Macrophages in Diverse Phases of Skin Repair. J Immunol. 2010;184:3964-3977. doi: 10.4049/jimmunol.0903356 PMID: 20176743
41. Deonarine K, Panelli M, Stashower M, Jin P, Smith K, Slade H, et al. Gene expression profiling of cutaneous wound healing. J Transl Med. 2007;5:11. Available: http://www.translational-medicine.com/content/5/1/11 PMID: 17313672
42. Warren KS. A functional classification of granulomatous inflammation. Ann N Y Acad Sci. 1976;278:7-18. doi: 10.1111/j.1749-6632.1976.tb47011.x PMID: 786128
43. Sánchez-Espiridión B, Sánchez-Aguilera A, Montalbán C, Martin C, Martinez R, González-Carrero J, et al. A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffinembedded samples. Clin Cancer Res. 2009;15:1367-75. doi: 10.1158/1078-0432. CCR-08-1119 PMID: 19228737
44. Scott DW, Chan FC, Hong F, Rogic S, Tan KL, Meissner B, et al. Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma. J Clin Oncol. 2013;31:692-700. doi: 10.1200/JCO.2012.43.4589 PMID: 23182984
45. Vera-Lozada G, Scholl V, Barros MHM, Sisti D, Guescini M, Stocchi V, et al. Analysis of biological and technical variability in gene expression assays from formalin-fixed paraffin-embedded classical Hodgkin lymphomas. Exp Mol Pathol. 2014;97:433-9. doi: 10.1016/j.yexmp. 2014.09.014 PMID: 25236575
46. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11:889-896. Available: doi: 10.1038/ni.1937 PMID: 20856220
47. Qin H, Holdbrooks AT, Liu Y, Reynolds SL, Yanagisawa LL, Benveniste EN. SOCS3 Deficiency Promotes M1 Macrophage Polarization and Inflammation. J Immunol. 2012;189:3439-3448. doi: 10. 4049/jimmunol.1201168 PMID: 22925925
48. Chetaille B, Bertucci F, Finetti P, Esterni B, Stamatoullas A, Picquenot JM, et al. Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood. 2009;113:2765-3775. doi: 10.1182/blood-2008-07-168096 PMID: 19096012
49. Greaves P, Clear A, Owen A, Iqbal S, Lee A, Matthews J, et al. Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells. Blood. 2013;122:2856-63. doi: 10.1182/blood-2013-06-508044 PMID: 24004665
50. Slivnick DJ, Ellis TM, Nawrocki JF, Fisher RI. The impact of Hodgkin's disease on the immune system. Semin Oncol. 2014;17:673-682. Available: http://www.seminoncol.org/article/0093-7754 (90) 90161-U/abstract
51. Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis. 2010;30:245-57. doi: 10.1055/s-0030-1255354 PMID: 20665377
52. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines. Immunity. 2014;41:14-20. doi: 10.1016/j. immuni.2014.06.008 PMID: 25035950
53. Fiorentino D, Bond M, Mosmann T. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170:2081-2095. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189521/PMID: 2531194
54. Anderson CF, Mosser DM. A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol. 2002;72:101-106. Available: http://www.jleukbio.org/content/72/1/101. abstract PMID: 12101268
55. Edwards JP, Zhang X, Frauwirth KA, Mosser DM. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol. 2006;80:1298-1307. doi: 10.1189/jlb.0406249 PMID: 16905575
56. Schoof N, Franklin J, Fürst R, Zander T, von Bonin F, Peyrade F, et al. Interleukin-10 Gene Polymorphisms are Associated With Freedom From Treatment Failure for Patients With Hodgkin Lymphoma. Oncol. 2013;18:80-89. doi: 10.1634/theoncologist.2012-0291
57. Baiocchi OCG. Hodgkin lymphoma and interleukin-10: shall we go down from the tip of the iceberg? Leuk Lymphoma. 2008;49:2031-2032. doi: 10.1080/10428190802517799 PMID: 19021042
58. Hohaus S, Giachelia M, Massini G, Vannata B, Criscuolo M, Martini M, et al. Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. Leuk Res. 2015;33:1352-1356. doi: 10.1016/j.leukres.2009.01.009
59. Vassilakopoulos TP, Nadali G, Angelopoulou MK, Siakantaris MP, Dimopoulou MN, Kontopidou FN, et al. Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma. Haematologica. 2001;86:274-281. Available: http://www.haematologica.org/content/86/3/274.abstract PMID: 11255274
60. Gjuvsland AB, Plahte E, Omholt SW. Threshold-dominated regulation hides genetic variation in gene expression networks. BMC Syst Biol. 2007;1:57. doi: 10.1186/1752-0509-1-57 PMID: 18062810
61. Jiang SL, Samols D, Rzewnicki D, Macintyre SS, Greber I, Sipe J, et al. Kinetic modeling and mathematical analysis indicate that acute phase gene expression in Hep 3B cells is regulated by both transcriptional and posttranscriptional mechanisms. J Clin Invest. 1995;95:1253-1261. Available: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC441464/PMID: 7883974
62. Roussel Y, Harris A, Lee MH, Wilks M. Novel methods of quantitative real-time PCR data analysis in a murine Helicobacter pylori vaccine model. Vaccine. 2007;25:2919-2929. doi: 10.1016/j.vaccine.2006. 07.013 PMID: 16905224
63. Harris J, Jain S, Ren Q, Zarineh A, Liu C, Ibrahim S. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma. Diagn Pathol. 2012;7:12. doi: 10.1186/1746-1596-7-12 PMID: 22289504
64. Zaki MAA, Wada N, Ikeda J, Shibayama H, Hashimoto K, Yamagami T, et al. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Virchows Arch. 2011;459:361-6. doi: 10.1007/s00428-011-1140-8 PMID: 21874508
65. Vakkila J, Lotze MT, Riga C, Jaffe R. A basis for distinguishing cultured dendritic cells and macrophages in cytospins and fixed sections. Pediatr Dev Pathol. 2005;8:43-51. doi: 10.1007/s10024-004-5045-2 PMID: 15717117
66. Högger P, Dreier J, Droste A, Buck F, Sorg C. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol. 1998;161:1883-90. Available: http://www.ncbi.nlm.nih.gov/pubmed/9712057 PMID: 9712057
67. Jakovic LR, Mihaljevic BS, Perunicic Jovanovic MD, Bogdanovic AD, Andjelic BM, Bumbasirevic VZ. The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma. Leuk Lymphoma. 2011;52:1913-9. doi: 10.3109/10428194.2011.580026 PMID: 21663512
68. Heusinkveld M, van der Burg SH. Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med. 2011;9:216. doi: 10.1186/1479-5876-9-216 PMID: 22176642
69. Medrek C, Pontén F, Jirström K, Leandersson K. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer. 2012;12:306. doi: 10. 1186/1471-2407-12-306 PMID: 22824040
70. Fujii N, Shomori K, Shiomi T, Nakabayashi M, Takeda C, Ryoke K, et al. Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance. J oral Pathol Med. 2012;41:444-51. doi: 10.1111/j.1600-0714.2012.01127.x PMID: 22296275
71. Komohara Y, Hasita H, Ohnishi K, Fujiwara Y, Suzu S, Eto M, et al. Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci. 2011;102:1424-31. doi: 10.1111/j. 1349-7006.2011.01945.x PMID: 21453387
72. Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F, et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res. 2011;167:e211-9. doi: 10.1016/j.jss. 2009.05.026 PMID: 19765725
73. Chaplin DD. Overview of the immune response. J Allergy Clin Immunol. 2010;125:S3-S23. doi: 10. 1016/j.jaci.2009.12.980 PMID: 20176265
74. Bonilla FA, Oettgen HC. Adaptive immunity. J Allergy Clin Immunol. 2010;125:S33-40. doi: 10.1016/j. jaci.2009.09.017 PMID: 20061006
75. Scott DW, Gascoyne RD. The tumour microenvironment in B cell lymphomas. Nat Rev Cancer. 2014;14:517-534. Available: doi: 10.1038/nrc3774 PMID: 25008267
76. Qian B-Z, Pollard JW. Macrophage Diversity Enhances Tumor Progression and Metastasis. Cell. 2014;141:39-51. doi: 10.1016/j.cell.2010.03.014
77. Diehl V. Are macrophages the bad guys in Hodgkin lymphoma? Nat Rev Clin Oncol. 2010;7:301-2. doi: 10.1038/nrclinonc.2010.71 PMID: 20517336